Globalspace Technologies Ltd

Globalspace Technologies Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The window will remain shut from Thursday, October 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. The date for the board meeting to consider these results will be announced later. Designated individuals are strictly prohibited from trading in the company's securities during this period.

Globalspace Technologies Ltd has announced its 16th Annual General Meeting (AGM) will be held on Tuesday, September 29, 2026, at 03:30 P.M. via Video Conferencing. The company is sending letters to members whose email addresses are not registered, providing links to the Annual Report for FY 2025-26 and the AGM notice. This communication also serves as a reminder for members holding physical securities to update their KYC details as per SEBI regulations, including PAN, address, mobile number, and bank account details, to be eligible for payments like dividends. E-voting will be open from September 26 to September 28, 2026.

Globalspace Technologies Ltd has released its Annual Report for the Financial Year 2025-2026. The report details the company's strategic shift towards an AI-led Health & Pharma Tech ecosystem, focusing on practical AI deployment and commercial application. Key initiatives include leveraging existing platforms like DocExa and MediOla to build scalable AI solutions and a unified AI platform for the healthcare sector. The company aims to launch an evolved AI platform by the end of FY 2026-27, targeting recurring revenue streams and strengthening its position in health tech. The 16th Annual General Meeting is scheduled for September 29, 2026, via video conferencing.

Globalspace Technologies Ltd has announced its 16th Annual General Meeting (AGM) to be held on Tuesday, September 29, 2026, at 03:30 P.M. via video conferencing. The meeting will address several key agenda items, including the adoption of the Audited Financial Statements for the Financial Year ended March 31, 2026. Other significant proposals include the re-appointment of Mrs. Beauty Krishna Murari Singh as a Non-Executive Non-Independent Director, the re-appointment of Mr. Girish Kasaragode Mallya as an Independent Director for a second term, and the ratification of material related party transactions with M/s Makebot Robotic Solutions Limited. Additionally, the company plans to approve a material related party transaction with M/s Makebot Robotic Solutions Private Limited for the upcoming financial year and the re-appointment of Mr. Krishna Murari Singh as Managing Director for a five-year term with his remuneration.

Globalspace Technologies Ltd announced the re-appointment of Mr. Girish Kasaragode Mallya as an Independent Director for a second term of five years, subject to member approval. The Board of Directors also approved the Un-Audited Financial Results for the quarter ended June 30, 2026, on a standalone and consolidated basis, along with the Limited Review Report. The 16th Annual General Meeting is scheduled for September 29, 2026. The trading window remains closed until 48 hours after the financial results announcement.

Globalspace Technologies Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results on August 14, 2026. The company also approved the re-appointment of Mr. Girish Kasaragode Mallya as an Independent Director for a second term. The 16th Annual General Meeting is scheduled for September 29, 2026. The trading window remains closed until 48 hours after the announcement of these results.

Globalspace Technologies Ltd announced that its Board of Directors, in a meeting held on August 14, 2026, approved the un-audited financial results for the quarter ended June 30, 2026. The results were prepared on a standalone and consolidated basis, along with a limited review report. The board also approved the re-appointment of Mr. Girish Kasaragode Mallya as an Independent Director for a second term of five years, subject to shareholder approval. The 16th Annual General Meeting is scheduled for September 29, 2026. The trading window remains closed until 48 hours after the announcement of the Q1 FY27 results.

Globalspace Technologies Ltd has announced a Board of Directors meeting scheduled for August 14, 2026. The primary agenda is to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. The company also informed that the trading window, which closed on July 1, 2026, will reopen 48 hours after the declaration of these financial results.

Globalspace Technologies Ltd has announced the closure of its trading window for designated persons and their immediate relatives, effective from July 1, 2026. This closure is in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain shut until 48 hours after the declaration of the company's unaudited financial results for the quarter ending June 30, 2026. The exact date of the board meeting to consider these results will be communicated later. Designated individuals are reminded to adhere to the insider trading regulations and refrain from trading company securities during this period.

Globalspace Technologies Ltd announced the acquisition of an additional 99.83% shareholding in its subsidiary, Miljon Mediapp Private Limited. This acquisition is achieved through the conversion of a loan amounting to ₹12.64 crore into equity. Miljon Mediapp operates in the Pharma Tech industry, providing a digital engagement platform for pharmaceutical companies. The company expects the acquisition to be completed by July 31, 2026. This move is not considered a related party transaction and does not require regulatory approvals.